Posts by tag
oncodaily
Artificial Sweetener Reduces Response to Immunotherapy
Could artificial sweeteners undo the benefits of immunotherapy? A study published in Cancer Discovery, July 30, found that melanoma and non-small cell lung cancer (NSCLC) patients who consume high levels of the artificial sweetener sucralose have worse responses to immunotherapy…
The Life Journey of Giuseppe Curigliano: From Becoming an Expert to Making Experts
From Rome to Milan to ESMO’s presidency — a story of science, courage, and mentorship. I am in Yerevan. Giuseppe Curigliano is in Milan, just back from Asia. “JSMO, CSCO, Korea, Japan, China…” he sighs, then laughs. “Too much travel?”…
CancerWorld #108 (October 2025)
CancerWorld is a platform for telling human stories that unfold across science, politics, and society, going beyond the investigation of cancer biology and therapy. In our October 2025 issue, we open with one of two cover stories: the profile of…
From Oceans to Organs: The Alarming Cancer Risks of Microplastics
Given the global estimate that approximately 9 to 14 million metric tons of plastic enter the oceans yearly—continuing to fragment into microplastics (MPs)—the urgency to understand their potential health effects has escalated. Particularly concerning is the growing body of evidence…
Social Media in Oncology – Between Empowerment and Risk
In oncology, communication has always been central – but in the digital age, it increasingly unfolds online. Platforms like Instagram, TikTok, Facebook, and X have become arenas where cancer journeys are shared, interpreted – and sometimes dangerously distorted. For patients…
The Apparent Cancer Paradox of Latvia
Latvia consistently ranks among the European Union's most troubled countries when it comes to cancer. The country lags behind EU countries on many cancer risk factors and also has one of the biggest gender disparities on the continent, with men…
Could Radiotherapy Offer Unexpected Protection Against Alzheimer’s Disease?
Women who survive breast cancer may face a surprising advantage: a lower risk of developing Alzheimer’s disease than their peers without cancer. The cohort study, published in JAMA Network Open, 20 June, found that breast cancer survivors had an 8%…
Detecting Cancer Before It Strikes: The Promise of Combination Early Detection and Interception
For decades, early cancer detection has predominantly relied on organ-specific screening programs—such as mammography, Pap test, or colonoscopy—to detect malignancies as early as possible. While these approaches have indisputably saved lives, they inherently capture only a limited range of cancers,…
What About Them, the Caregivers?
“The anticipatory fear that I had became reality when the doctor said that my 6-year-old son must undergo chemotherapy…the rest of the explanation I didn’t hear due to the shock that I had, even though I am a radiology nurse…
She’s Gone and Done It: The Story of Dr. Nageatte Ibrahim
Dr. Nageatte Ibrahim has spent her career at the intersection of oncology, science, and medicine, with achievements resulting in global impacts. Trained as a physician and scientist, she played a central role in the development of Keytruda, one of the…